Biological Products, (No Diagnostic Substances)·ZUG
Financials
20 shown
Type
Period
Ended
Filed
10-K
FY 2025
12/31/25
2/12/26
→
10-Q
Q3 2025
9/30/25
11/10/25
→
10-Q
Q2 2025
6/30/25
8/4/25
→
10-Q
Q1 2025
3/31/25
5/6/25
→
10-K
FY 2024
12/31/24
2/11/25
→
10-Q
Q3 2024
9/30/24
11/5/24
→
↓
Earnings Releases (8-K)
25 shown
Filed
Period
2/12/26
Q1 FY2026
→
11/10/25
Q4 FY2025
→
8/4/25
Q3 FY2025
→
5/6/25
Q2 FY2025
→
2/11/25
Q1 FY2025
→
11/5/24
Q4 FY2024
→
↓
News (8-K)
55 shown
Filed
Type
Description
1/12/26
Other
Other Events
→
10/15/25
Other
Other Events
→
6/26/25
Other
Other Events
→
6/9/25
Vote
Amendments to Articles of Incorporation or Bylaws
→
5/19/25
Agreement
Entry into a Material Definitive Agreement
→
3/26/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
↓
Prospectuses & Registrations
37 shown
Filed
Form
Description
10/15/25
424B5
424B5
→
5/19/25
424B5
424B5
→
4/16/25
ARS
ARS
→
8/5/24
S-3ASR
FORM S-3ASR
→
8/5/24
S-8
S-8
→
4/9/24
ARS
ARS
→
↓
Filing History(816 filings)
TypeDateAccessionPeriodSize
4
Feb 20, 2026
0001193125-26-0617124
Feb 18, 2026
8.8 KB
4
Feb 20, 2026
0001193125-26-0617104
Feb 18, 2026
8.7 KB
SCHEDULE 13G/A
Feb 17, 2026
0000940594-26-000006
—
10.2 KB
10-K
Feb 12, 2026
0001193125-26-04895710-K
Dec 31, 2025
23.3 MB
8-K
Feb 12, 2026
0001193125-26-0488738-K
Feb 12, 2026
407.5 KB
SCHEDULE 13G/A
Feb 5, 2026
0001562230-26-000001
—
7.3 KB
4
Jan 27, 2026
0001193125-26-0249554
Apr 3, 2025
5.0 KB
4
Jan 26, 2026
0001193125-26-0228454
Jan 22, 2026
8.6 KB
4
Jan 22, 2026
0001193125-26-0197334
Jan 20, 2026
9.5 KB
144
Jan 22, 2026
0001958244-26-000050
—
6.6 KB
144
Jan 22, 2026
0001950047-26-000625
—
6.0 KB
144
Jan 20, 2026
0001958244-26-000046
—
11.9 KB
8-K
Jan 12, 2026
0001193125-26-0098808-K
Jan 12, 2026
163.6 KB
4
Jan 8, 2026
0001193125-26-0078754
Jan 6, 2026
15.4 KB
144
Jan 6, 2026
0001950047-26-000216
—
5.3 KB
4
Dec 23, 2025
0001193125-25-3311624
Dec 22, 2025
8.8 KB
4
Dec 22, 2025
0001193125-25-3290104
Dec 18, 2025
5.0 KB
144
Dec 22, 2025
0001950047-25-010601
—
5.2 KB
SCHEDULE 13G
Nov 14, 2025
0000940594-25-000008
—
16.0 KB
10-Q
Nov 10, 2025
0001193125-25-27333710-Q
Sep 30, 2025
9.4 MB
8-K
Nov 10, 2025
0001193125-25-2733298-K
Nov 10, 2025
418.9 KB
SCHEDULE 13G/A
Nov 4, 2025
0001104659-25-106355
—
13.4 KB
4
Oct 20, 2025
0001193125-25-2438194
Oct 16, 2025
9.3 KB
4
Oct 15, 2025
0001193125-25-2404384
Oct 13, 2025
9.3 KB
4
Oct 15, 2025
0001193125-25-2404374
Oct 13, 2025
8.8 KB
25 filings shown
CRISPR Therapeutics AG — SlamSEC
Proxies
29 shown
Filed
Form
Description
4/16/25
DEFA14A
DEFA14A
→
4/16/25
DEF 14A
DEF 14A
→
4/3/25
PRE 14A
PRE 14A
→
4/9/24
DEFA14A
DEFA14A
→
4/9/24
DEF 14A
DEF 14A
→
3/27/24
PRE 14A
PRE 14A
→
↓
Ownership
40 shown
Filed
Form
Description
2/20/26
4
4
→
2/20/26
4
4
→
1/27/26
4
4
→
1/26/26
4
4
→
1/22/26
4
4
→
1/8/26
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
2/17/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/5/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
1/22/26
144
144
→
1/22/26
144
144
→
1/20/26
144
144
→
1/6/26
144
144
→
↓
CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. Each sequence within an individual prokaryotic CRISPR is derived from a DNA fragment of a bacteriophage that had previously infected the prokaryote or one of its ancestors.